← Back to Search

Tube Thoracostomy

Chest Tube Drainage for Hemothorax (HemoTxRCT Trial)

N/A

Recruiting

Led By Chad G Ball, MD

Research Sponsored by University of Calgary

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age >= 18 years

Blunt thoracic injury

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 30 days after patients recruited in the study

Awards & highlights

HemoTxRCT Trial Summary

This trial is testing whether small to moderate HTXs can be absorbed without intervention (chest tube drainage).

Who is the study for?

This trial is for adults over 18 with blunt chest injuries and a hemothorax detected by CT scan. It's not for those who are unstable due to the injury, need urgent tube placement, have penetrating injuries, already have a chest tube, were admitted over 24 hours ago, or have severe chest fractures or respiratory distress from the hemothorax.Check my eligibility

What is being tested?

The study compares two ways to manage traumatic hemothoraces: inserting a chest tube drain versus expectant management (close monitoring without immediate intervention). The goal is to determine when each method should be used for better patient outcomes.See study design

What are the potential side effects?

Chest tube drainage can lead to complications such as organ injury and infections in some patients. Expectant management avoids these risks but may delay necessary treatment if the condition worsens.

HemoTxRCT Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I have had a chest injury without any cuts.

HemoTxRCT Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 30 days after patients recruited in the study

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~30 days after patients recruited in the study

This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days after patients recruited in the study for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

The numbers of hemothoraces that require thoracic interventions.

Secondary outcome measures

The days of intensive care unit stay

Mechanical ventilation

HemoTxRCT Trial Design

2Treatment groups

Active Control

Placebo Group

Group I: Chest tube drainActive Control1 Intervention

A chest tube placed with the intent of draining all intra-pleural blood.

Group II: Expectant managementPlacebo Group1 Intervention

No chest tube, but will undergo standard observation/conservative management by the trauma service.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of CalgaryLead Sponsor

792 Previous Clinical Trials

868,954 Total Patients Enrolled

Alberta Health servicesOTHER

158 Previous Clinical Trials

649,466 Total Patients Enrolled

Chad G Ball, MDPrincipal InvestigatorUniversity of Calgary

Media Library

Chest tube drain (Tube Thoracostomy) Clinical Trial Eligibility Overview. Trial Name: NCT03050502 — N/A

Hemothorax Research Study Groups: Chest tube drain, Expectant management

Hemothorax Clinical Trial 2023: Chest tube drain Highlights & Side Effects. Trial Name: NCT03050502 — N/A

Chest tube drain (Tube Thoracostomy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03050502 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the projected number of individuals who will be taking part in this trial?

"Affirmative. Clinicaltrials.gov's records show that the medical trial, which was first posted on February 1st 2018, is still accepting registrants. 200 patients need to be recruited from 2 locations for this project."

Answered by AI

Is this research endeavor actively seeking participants?

"Affirmative. Details available on clinicaltrials.gov demonstrate that this medical trial, which was initially posted in February of 2018, is currently enrolling participants. The study requires 200 individuals to be recruited from two separate locations."

Answered by AI

Is there a possibility of me enrolling in this medical experiment?

"To meet the eligibility requirements for this clinical trial, prospective participants must have thoracic traumas and be within 18 to 100 years of age. Currently, approximately 200 people are being enrolled in the study."

Answered by AI